Ixekizumab Improves Outcomes of Ankylosing Spondylitis Ixekizumab Improves Outcomes of Ankylosing Spondylitis
Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - November 6, 2018 Category: Orthopaedics Tags: Rheumatology News Source Type: news

Long-term Secukinumab Effective for Ankylosing Spondylitis Long-term Secukinumab Effective for Ankylosing Spondylitis
The long-term results are welcome news because about half of patients do not respond to TNF inhibitors, which are the only treatment currently available for ankylosing spondylitis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 26, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Immune therapy generates promising results in hard-to-treat ankylosing spondylitis
(Wiley) Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis (AS), a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may have another treatment option in the biologic drug ixekizumab. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 20, 2018 Category: International Medicine & Public Health Source Type: news

Amgen Releases AMGEVITA for Treatment of Inflammatory Diseases in Adults
The AMGEVITA is a biosimilar designed to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, psoriasis hidradenitis and panuveitis. The biosimilar is a citrate-free formula and will be released in twenty-eight  countries in the European Union.This story is related to the following:Biopharmaceuticals (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - October 18, 2018 Category: Medical Devices Source Type: news

Novartis 5-year data in psoriatic arthritis and ankylosing spondylitis reinforces Cosentyx ® leadership in spondyloarthritis
Novartis, a leader in immuno-dermatology and rheumatology, announced today it will be presenting five-year data from the ongoing extensions of the phase III FUTURE 1 and MEASURE 1 studies for Cosentyx® (secukinumab) in patients with psoriatic arthritis (PsA)[1] and ankylosing spondylitis (AS)[2] respectively. (Source: World Pharma News)
Source: World Pharma News - October 16, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Amgen Launches AMGEVITA ™ (Biosimilar Adalimumab) In Markets Across Europe
First Inflammation Biosimilar From Amgen's Portfolio to Launch in Europe THOUSAND OAKS, Calif., Oct. 15, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that AMGEVITATM, a biosimilar to adalimumab, will launch in markets across Europe beginning on Oct. 16, 2018. AMGEVITA is the first adalimumab biosimilar to be approved by the European Commission (EC). AMGEVITA is authorized for the treatment of inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis; psoriatic arthritis; severe active ankylosing spondylitis (AS); severe axial spondyloarthritis without radiographic evidenc...
Source: Amgen News Release - October 16, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Biologics Less Effective for Ankylosing Spondylitis in Women Biologics Less Effective for Ankylosing Spondylitis in Women
Women and men with ankylosing spondylitis respond differently to TNF inhibitor therapy, and researchers are trying to determine why that is.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 6, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Stromal Vascular Fraction Treatment for Osteoarthritis Stromal Vascular Fraction Treatment for Osteoarthritis
A novel stem-cell therapy with stromal vascular fraction resulted in dramatic improvements to this patient's osteoarthritis and comorbidities including ankylosing spondylitis, depression, and fatigue.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 19, 2018 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Ankylosing Spondylitis: No Special Infection Risk from Treatment
(MedPage Today) -- DMARDs, TNF inhibitors appear safe in this regard (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - September 8, 2018 Category: Primary Care Source Type: news

Lilly Announces Positive Top-Line Results for Second Phase 3 Study of Taltz(R) (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis) for TNF Inhibitor-Experienced Patients
INDIANAPOLIS, June 28, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that Taltz® (ixekizumab) met the primary and major secondary endpoints in COAST-W, a Phase 3 study evaluating the safety and eff... Biopharmaceuticals Eli Lilly, Taltz, ixekizumab, Ankylosing Spondylitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 28, 2018 Category: Pharmaceuticals Source Type: news

Risankizumab Fails in Spine Disease (CME/CE)
(MedPage Today) -- Blocking IL-23 not a winning strategy in ankylosing spondylitis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 27, 2018 Category: Primary Care Source Type: news

Ankylosing Spondylitis Patients at Risk for Self-Harm Ankylosing Spondylitis Patients at Risk for Self-Harm
People with this painful condition that affects the spine are at higher risk of harming themselves, a large study confirms; however, the mental health effects of the disease are often ignored.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 15, 2018 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Significant increase in self-harm attempts following ankylosing spondylitis diagnosis
(European League Against Rheumatism) The results of a population study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate a significantly increased rate of self-harm attempts in inflammatory arthritis (IA), particularly following a diagnosis of Ankylosing Spondylitis (AS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2018 Category: International Medicine & Public Health Source Type: news

Combining NSAIDs and TNFi may reduce radiographic progression in ankylosing spondylitis
(European League Against Rheumatism) The results of a cohort study presented at the Annual European Congress of Rheumatology (EULAR 2018) showed that, in patients with ankylosing spondylitis (AS) taking tumour necrosis factor (TNF) inhibitors, the addition of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with significantly less radiographic progression in a dose-related manner at four years. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2018 Category: International Medicine & Public Health Source Type: news

Imagine Dragons' Dan Reynolds opens up on health struggles
Reynolds has ankylosing spondylitis, an inflammatory disease that once caused the singer crippling amounts of pain (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 11, 2018 Category: Consumer Health News Source Type: news

Managing Morbidity and Treatment-Related Toxicity in AS Managing Morbidity and Treatment-Related Toxicity in AS
Find out more about the morbidities associated with ankylosing spondylitis and its treatment, and learn how to best manage them.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 9, 2018 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Efficacy, Safety, and Tolerability of Secukinumab in AS Efficacy, Safety, and Tolerability of Secukinumab in AS
Is secukinumab a safe and effective treatment choice for patients with ankylosing spondylitis?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 11, 2018 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

EMA Committee Backs Remicade Biosimilar Zessly EMA Committee Backs Remicade Biosimilar Zessly
The committee favors marketing the infliximab biosimilar product Zessly for treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and psoriasis.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 23, 2018 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Lilly Announces Positive Top-Line Phase 3 Results for Taltz(R) (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)
INDIANAPOLIS, Feb. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that Taltz® (ixekizumab) met the primary and all key secondary endpoints in COAST-V, a Phase 3 study evaluating the safety and e... Biopharmaceuticals Eli Lilly, Taltz, ixekizumab, Ankylosing Spondylitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 13, 2018 Category: Pharmaceuticals Source Type: news

Factors Affecting Blood Loss During Total Hip Arthroplasty in Patients With Ankylosing Spondylitis
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - January 17, 2018 Category: Orthopaedics Tags: CME Article Source Type: news

Novartis advances head-to-head superiority trials of Cosentyx ® versus Humira®* and proposed biosimilar adalimumab**
Novartis announced today the initiation of SURPASS, a head-to-head clinical trial of Cosentyx® (secukinumab) versus proposed biosimilar adalimumab** in ankylosing spondylitis (AS). SURPASS is the first head-to-head clinical trial in AS investigating superiority of Cosentyx in slowing spinal bone damage versus proposed biosimilar adalimumab**. SURPASS is currently recruiting patients, with the 'first patient first visit' already achieved in November 2017. (Source: World Pharma News)
Source: World Pharma News - January 9, 2018 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news

Anti-IL17 Benefits Persist in Spine Disease (CME/CE)
(MedPage Today) -- Rapid responses seen for secukinumab in ankylosing spondylitis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - December 27, 2017 Category: Primary Care Source Type: news

Juliette and Kirran explain what working on our campaign has meant to them
Arthritis Research UK’sThe Nation’s Joint Problem campaign has reached millions of people over the last three months, through national news stories and features and TV, cinema and billboard advertising. We asked two people who helped to shape the campaign content about their experience of being part of our ground-breaking push to change attitudes to arthritis.JulietteJournalist and author ofMostly Cloudy, Some Bright Spells Juliette Wills, 45, has lived with inflammatory spinal arthritis for 18 years. She wrote thesix powerful stories featured in The Guardian which exposed the hidden impact of arthritis, as wel...
Source: Arthritis Research UK - November 24, 2017 Category: Rheumatology Source Type: news

Patients' drugs fail to arrive  at their homes
The 42-year-old teacher has ankylosing spondylitis — a type of inflammatory arthritis which mainly affects the spine — and has been treating it with injections of etanercept since 2009. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2017 Category: Consumer Health News Source Type: news

The patients left in despair as drugs fail to arrive  
The 42-year-old teacher has ankylosing spondylitis — a type of inflammatory arthritis which mainly affects the spine — and has been treating it with injections of etanercept since 2009. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2017 Category: Consumer Health News Source Type: news

Golimumab Gets FDA Nod for Two New Indications Golimumab Gets FDA Nod for Two New Indications
The TNF-alpha inhibitor significantly improved the signs and symptoms of psoriatic arthritis and ankylosing spondylitis in phase 3 testing.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 24, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Janssen receives two u.s. fda approvals for simponi aria ® (golimumab) for the treatment of adults with active psoriatic arthritis or active ankylosing spondylitis
SIMPONI ARIA ® is the Only Fully-Human Anti-TNF-alpha Infused Therapy Now Approved for Psoriatic Arthritis, Ankylosing Spondylitis and Rheumatoid Arthritis (Source: Johnson and Johnson)
Source: Johnson and Johnson - October 21, 2017 Category: Pharmaceuticals Source Type: news

FDA Approves Simponi Aria (golimumab) for the Treatment of Adults With Active Psoriatic Arthritis or Active Ankylosing Spondylitis
Horsham, Pa., October 20, 2017 ― Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved Simponi Aria (golimumab), the only fully-human anti-tumor necrosis factor (TNF)-alpha therapy administered via a... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 20, 2017 Category: Drugs & Pharmacology Source Type: news

Inflammatory Spinal Disorders Common in IBD Patients Inflammatory Spinal Disorders Common in IBD Patients
Ankylosing spondylitis (AS), axial spondyloarthritis (SpA) and inflammatory back pain are common in inflammatory bowel disease (IBD) patients two decades after IBD diagnosis, according to findings from the IBSEN study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Ankylosing Spondylitis Quiz: Symptoms & Treatment
Title: Ankylosing Spondylitis Quiz: Symptoms& TreatmentCategory: MedicineNet QuizCreated: 1/16/2013 12:00:00 AMLast Editorial Review: 9/20/2017 1:05:25 PM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - September 20, 2017 Category: Rheumatology Source Type: news

Tofacitinib in Patients With Ankylosing Spondylitis Tofacitinib in Patients With Ankylosing Spondylitis
How do different doses of tofacitinib compare in terms of safety and efficacy?Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 12, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

What Are the Side Effects of Prednisone for Ankylosing Spondylitis?
Title: What Are the Side Effects of Prednisone for Ankylosing Spondylitis?Category: Doctor's& Expert's views on SymptomsCreated: 8/29/2017 12:00:00 AMLast Editorial Review: 8/29/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 29, 2017 Category: Rheumatology Source Type: news

Back pain and fatigue? Symptoms could be warning sign of THIS form of arthritis
ARTHRITIS - inflammation of the joints - and back pain, are symptoms of long term chronic condition Ankylosing spondylitis . (Source: Daily Express - Health)
Source: Daily Express - Health - August 21, 2017 Category: Consumer Health News Source Type: news

New study highlights key quality of life factors for ankylosing spondylitis
A new study has shed light on some of the most prevalent modifiable factors that predict a poor quality of life in people withankylosing spondylitis. Moreover, the University of Aberdeen research indicated that some of these factors - which include pain,fatigue and poor physical function - are currently better monitored than others, suggesting new approaches to treating this painful condition may be needed. The most important predictors for poor quality of life The study analysed data from 959 patients involved in the Scotland Registry for Ankylosing Spondylitis, which collected clinical and patient-reported data on ankylo...
Source: Arthritis Research UK - August 16, 2017 Category: Rheumatology Source Type: news

Anesthesia for Hip Replacement in Ankylosing Spondylitis Anesthesia for Hip Replacement in Ankylosing Spondylitis
Anesthesia management in ankylosing spondylitis is challenging. This case series presents a novel analgesia protocol for total hip replacement in patients with ankylosing spondylitis.BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 26, 2017 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Merck launches biosimilar version of J & J blockbuster Remicade
Merck and Co. Inc. on Monday became the second pharmaceutical company to launch a biosimilar version of Remicade, a drug that generates billions of dollars a year in sales for Johnson& Johnson. Renflexis, the Merck biosimilar product, was approved by the Food and Drug Administration on April 21 as a treatment for rheumatoid arthritis, Crohn's disease, ulcerative colitis and ankylosing spondylitis. It is the first medicine available in the United States under a global biosimilars develop ment and… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 24, 2017 Category: Health Management Authors: John George Source Type: news

Statins Linked to Reduced Mortality in Ankylosing Spondylitis Statins Linked to Reduced Mortality in Ankylosing Spondylitis
Patients with ankylosing spondylitis who began taking a statin had a 37% reduction in mortality compared with similar patients who did not take statins.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 21, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Statins May Lengthen Life in AS (CME/CE)
(MedPage Today) -- Over 30% drop in all-cause mortality patients with ankylosing spondylitis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 18, 2017 Category: Cardiology Source Type: news

7 medtech stories we missed this week: June 30, 2017
[Image from unsplash.com]From ConforMIS touting its knee replacement study to Consulting Radiologists’s new breast cancer detection tool, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Study: Low-dose CT scanning improves Ankylosing Spondylitis assessment A new study has shown that low-dose computed tomography (LD-CT) is more sensitive than X-rays for monitoring disease progression in people who have Ankylosing Spondylitis, according to a June 15 press release. LD-CT has previously been proven to be sensitive and reliable when assessing bone growth in different pat...
Source: Mass Device - June 30, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Big Data Business/Financial News Cardiac Assist Devices Cardiovascular Clinical Trials Diagnostics Implants Oncology Research & Development Respiratory Cefaly conformis Consulting Radiologists Hemovent Image Stream Medical Me Source Type: news

Anti - TNF - α Rx Improves Sleep Quality in Ankylosing Spondylitis
Patients see reduction in PSQI scores, but no change in polysomnography parameters (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - June 24, 2017 Category: Respiratory Medicine Tags: Family Medicine, Internal Medicine, Nursing, Orthopedics, Pharmacy, Pulmonology, Rheumatology, Anesthesiology & Pain, Journal, Source Type: news

Novartis reports favourable data from Phase III extension trial of Cosentyx for AS
Novartis has reported positive results from the Phase III MEASURE 1 extension trial of Cosentyx (secukinumab) to treat patients with active ankylosing spondylitis (AS). (Source: Drug Development Technology)
Source: Drug Development Technology - June 18, 2017 Category: Pharmaceuticals Source Type: news

Low-dose CT scanning improves assessment of ankylosing spondylitis patients
(European League Against Rheumatism) The results of a study presented today at the Annual European Congress of Rheumatology 2017 showed that low dose computed tomography is more sensitive than conventional radiographs (X-rays) in the monitoring of disease progression in patients with Ankylosing Spondylitis (AS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 15, 2017 Category: International Medicine & Public Health Source Type: news

Medical News Today: Best exercises and postures for ankylosing spondylitis
Following an exercise routine can help people with ankylosing spondylitis manage their symptoms and slow the progression of the condition. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 10, 2017 Category: Consumer Health News Tags: Back Pain Source Type: news

State of Musculoskeletal Health 2017
We are delighted to announce the launch of theState of Musculoskeletal Health 2017.The compendium report, to be updated annually, is a comprehensive one-stop data source of information and statistics on the prevalence, incidence, risk factors, comorbidities and impact of the most prevalent musculoskeletal conditions in the UK. What conditions are included?1. Inflammatory conditionsAxial Spondyloarthritis (including ankylosing spondylitis)GoutJuvenile idiopathic arthritisRheumatoid arthritis2. Musculoskeletal painOsteoarthritisBack pain3. Osteoporosis and fragility fracturesThe State of Musculoskeletal Health 2017...
Source: Arthritis Research UK - May 31, 2017 Category: Rheumatology Source Type: news

State of Musculoskeletal Health 2017 report
We are delighted to announce the launch of theState of Musculoskeletal Health 2017 report.The compendium report, to be updated annually, is a comprehensive one-stop data source of information and statistics on the prevalence, incidence, risk factors, comorbidities and impact of the most prevalent musculoskeletal conditions in the UK. What conditions are included?1. Inflammatory conditionsAxial Spondyloarthritis (including ankylosing spondylitis)GoutJuvenile idiopathic arthritisRheumatoid arthritis2. Musculoskeletal painOsteoarthritisBack pain3. Osteoporosis and fragility fracturesThe State of Musculoskeletal...
Source: Arthritis Research UK - May 31, 2017 Category: Rheumatology Source Type: news

Arthritis symptoms - CURE on the horizon for this painful condition
ARTHRITIS - inflammation of the joints and back pain - are symptoms of long term chronic condition Ankylosing spondylitis . (Source: Daily Express - Health)
Source: Daily Express - Health - May 30, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Ankylosing spondylitis: Pictures, early signs, and progression
in this article, learn about ankylosing spondylitis which is a type of arthritis. What are the symptoms, how is it diagnosed, and how might it be treated? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 29, 2017 Category: Consumer Health News Tags: Back Pain Source Type: news

Medical News Today: Diet tips for managing ankylosing spondylitis
What foods and nutrients are beneficial for ankylosing spondylitis and what foods should be avoided? What supplements are recommended? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 24, 2017 Category: Consumer Health News Tags: Back Pain Source Type: news